GOIN KATHLEEN (Chief Operating Officer) sold 4.30K shares of PALVELLA THERAPEUTICS, INC. on the open market
Open‑market sale worth $341.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/20/2026ACC: 0001104659-26-018136
Officer· Chief Operating Officer
Since Feb 2026
-4.30K
Net shares
Net seller
$341.6K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
4.30K acquired · 8.60K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+2.15K
Price / share
$7.14
Trade value
$15.38K
% of position
New position
2/18/2026
0.00→2.15K
Common Stock
Direct
Shares
+2.15K
Price / share
$9.08
Trade value
$19.50K
% of position
99.7%
2/18/2026
2.15K→4.30K
Common Stock
Direct
Shares
−3.03K
Price / share
$79.16
Trade value
$239.53K
% of position
70.3%
2/18/2026
4.30K→1.28K
Common Stock
Direct
Shares
−1.28K
Price / share
$79.97
Trade value
$102.04K
% of position
New position
2/18/2026
1.28K→0.00
Total
Net shares
+0.00
Net value
-$306.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | M · Option Exercise | +2.15K | $7.14 | $15.38K | New position | 0.00 | 2.15K |
| Common Stock Direct | 2/18/2026 | M · Option Exercise | +2.15K | $9.08 | $19.50K | 99.7% | 2.15K | 4.30K |
| Common Stock Direct | 2/18/2026 | S · Sale | −3.03K | $79.16 | $239.53K | 70.3% | 4.30K | 1.28K |
| Common Stock Direct | 2/18/2026 | S · Sale | −1.28K | $79.97 | $102.04K | New position | 1.28K | 0.00 |
| Total | +0.00 | -$306.68K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.15K shares
Shares
−2.15K
Strike price
7.14
Held after
17.24K
Exercisable
—
2/18/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.15K shares
Shares
−2.15K
Strike price
9.08
Held after
17.18K
Exercisable
—
2/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.15K shares | 2/18/2026 | M · Option Exercise | −2.15K | 7.14 | — | 17.24K |
| Stock Option (Right to Buy) Direct | Common Stock2.15K shares | 2/18/2026 | M · Option Exercise | −2.15K | 9.08 | — | 17.18K |